Research Advances Offer Optimism for the Future of Brain Tumor Treatments

In an interview with School of Medicine Dean Dr. Mary Klotman, Dr. David Ashley explains some of the challenges of treating brain tumors and the exciting advancements his team is pursuing, including the recent FDA approval of a drug for low-grade gliomas. Ashley, director of the brain tumor center, outlines the team’s interdisciplinary approach to developing the treatment